# Treatment of Acute Lymphoblastic Leukemia in Children

> **NCT00165178** · PHASE3 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 498 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** prednisone
- **DRUG:** dexamethasone
- **DRUG:** doxorubicin
- **DRUG:** E. coli asparaginase
- **DRUG:** vincristine
- **DRUG:** methotrexate
- **DRUG:** Leucovorin
- **DRUG:** Asparaginase
- **DRUG:** cytarabine
- **DRUG:** Methotrexate/Hydrocortisone

## Key facts

- **NCT ID:** NCT00165178
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2004-12
- **Final completion:** 2011-05
- **Target enrollment:** 498 (ACTUAL)
- **Last updated:** 2013-04-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165178, "Treatment of Acute Lymphoblastic Leukemia in Children". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00165178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*